Your browser doesn't support javascript.
loading
Complete longitudinal analyses of the randomized, placebo-controlled, phase III trial of sunitinib in patients with gastrointestinal stromal tumor following imatinib failure.
Demetri, George D; Garrett, Christopher R; Schöffski, Patrick; Shah, Manisha H; Verweij, Jaap; Leyvraz, Serge; Hurwitz, Herbert I; Pousa, Antonio Lopez; Le Cesne, Axel; Goldstein, David; Paz-Ares, Luis; Blay, Jean-Yves; McArthur, Grant A; Xu, Qiang Casey; Huang, Xin; Harmon, Charles S; Tassell, Vanessa; Cohen, Darrel P; Casali, Paolo G.
Affiliation
  • Demetri GD; Center for Sarcoma and Bone Oncology, Ludwig Center at Dana-Farber/Harvard Cancer Center, Dana-Farber Cancer Institute, 450 Brookline Ave., Dana 1212, Boston, MA 02215, USA. gdemetri@partners.org
Clin Cancer Res ; 18(11): 3170-9, 2012 Jun 01.
Article in En | MEDLINE | ID: mdl-22661587
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrroles / Gastrointestinal Stromal Tumors / Gastrointestinal Neoplasms / Indoles Type of study: Clinical_trials / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2012 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrroles / Gastrointestinal Stromal Tumors / Gastrointestinal Neoplasms / Indoles Type of study: Clinical_trials / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2012 Type: Article Affiliation country: United States